Lipopolysaccharide modulation of normal enterocyte turnover by toll-like receptors is mediated by endogenously produced tumour necrosis factor α

Gut

Volumn 51, Issue 6, 2002, Pages 842-848

  Ruemmele, F M ^a,b   Beaulieu, J F ^c   Dionne, S ^d   Levy, E ^d   Seidman, E G ^d   Cerf Bensussan, N ^b   Lentze, M J ^a  

^a UNIVERSITY OF BONN   (Germany)

^b INSERM   (France)

^c UNIVERSITÉ DE SHERBROOKE   (Canada)

^d UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CYTOKINE; ENDOTOXIN; ENDOTOXIN ANTIBODY; LIPOPOLYSACCHARIDE; MESSENGER RNA; PROTEIN P55; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY;

APOPTOSIS; ARTICLE; CELL LINE; CELL PROLIFERATION; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; GROWTH INHIBITION; GROWTH STIMULATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; INTESTINE CELL; INTESTINE EPITHELIUM CELL; PARACRINE SIGNALING; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD14; APOPTOSIS; CELL DIVISION; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DROSOPHILA PROTEINS; ENTEROCYTES; GENE EXPRESSION; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINE, SMALL; LIPOPOLYSACCHARIDES; MEMBRANE GLYCOPROTEINS; RECEPTORS, CELL SURFACE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036894985     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.51.6.842     Document Type: Article

References (38)

1. Dianda L, Hanby AM, Wright NA, et al. T cell receptor-alpha beta-deficient mice fail to develop colitis in the absence of a microbial environment. Am J Pathol 1997;150:91-7.
2. Schultz M, Tonkonogy SL, Sellon RK, et al. IL-2-deficient mice raised under germfree conditions develop delayed mild focal intestinal inflammation. Am J Physiol 1999;276:G1461-72.
3. Sellon RK, Tankanagy S, Schultz M, et al. Resident enteric bacteria are necessary for development of spontaneaus calitis and immune system activation in interleukin-10-deficient mice. Infect Immun 1998;66:5224-31.
4. Fiocchi C, Inflammatory bowel disease: Etiology and pathogenesis. Gastroenterology 1998;115:182-205.
5. Rutgeerts P, Geboues K, Peeters M, et al. Effect of fecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet 1991;ii:771-4.
6. Gardiner KR, Halliday MI, Barclay GR, et al. Significance of systemic endotoxaemia in inflammatory bowel disease. Gut 1995;36:897-901.
7. Svanborg C, Godaly G, Hedlund M. Cytokine responses during mucosal infections: Role in disease pathogenesis and host defense. Curr Oppin Microbiol 1999;2:99-105.
8. Parrilo JE. Pathogenetic mechanisms of septic shock. N Engl J Med 1993;328:1471.
9. Salkowski CA, Detore G, McNally R, et al. Regulation of inducible nitric oxide synthase messenger RNA expression and nitric oxide production by lipopolysaccharide in vivo. J Immunol 1997;158:905-12.
10. Kimura H, Sawada N, Tobioka H, et al. Bacterial lipopolysaccharide reduced intestinal barrier function and altered localization of 7H6 antigen in IEC6-rat intestinal crypt cells. J Cell Physiol 1997;171:284-90.
11. Unno N, Wang H, Menconi MJ, et al. Inhibition of inducible nitric oxide synthase ameliorates endotoxin induced gut mucosal barrier dysfunction in rats. Gastroenterology 1997;113:1246-57.
12. McGee DW, Bamberg T, Vitkus JD, et al. A synergistic relationship between TNF-α, IL-1β and TGF-β1 on IL-6 secretion by the IEC-6 intestinal epithelial cell line. Immunology 1995;86:6-11.
13. Schuerer-Maly CC, Eckmann L, Kagnoff MF, et al. Colonic epithelial cell lines as a source of interleukin-8: Stimulation by inflammatory cytokines and bacterial lipopolysaccharide. Immunology 1994;81:85-91.
14. Stadnyk AW. Cytokine production by epithelial cells. FASEB J 1994;8:1041-7.
15. Wright SD, Ramos RA, Tobias PS, et al. CD 14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990;249:1431-3.
16. Poltorak A, He X, Smirnova I, et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: Mutations in TIr4 gene. Science 1998;282:2085-8.
17. Yang RB, Mark MR, Gray A, et al. Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signaling. Nature 1998;395:284-8.
18. Perreault N, Beaulieu JF. Use of the dissociating enzyme thermolysin to generate viable human normal intestinal epithelial cell cultures. Exp Cell Res 1996,224:254-64.
19. Ruemmele FM, Russo P, Beaulieu J-F, et al. Susceptibility to FAS-induced apoptosis in human non-tumoral enterocytes - The role of co-stimulatory factors. J Cell Physiol 1999;181:45-54.
20. Ruemmele FM, Dionne S, Levy E, et al. TNFα-induced IEC-6 cell apoptosis requires activation of ICE-caspases whereas complete inhibition of the caspase-cascade led to necrotic cell death. Biochem Biophys Res Commun 1999;260:159-66.
21. Faure E, Equils O, Sieling PA, et al. Bacterial lipopolysaccharide activates NF-kappaB trough toll-like receptor 4 (TLR4) in cultured human dermal endothelial cells. J Biol Chem 2000;275:11058-63.
22. Abreu A, Vora P, Faure E, et al. Decreased expression of toll-like eeceptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. J Immunol 2001;167:1609-17.
23. Dionne S, D'Agata ID, Ruemmele FM, et al. Tyrasine kinase and MAPK inhibitan af TNF alpha and EGF stimulated IEC-6 cell grawth. Biochem Biophys Res Commun 1998;242:146-50.
24. Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature 2000;406:782-7.
25. Fiocchi C. Inflammatory bowel disease: Etiology and pathogenesis. Gastroenterology 1998;115:182-205.
26. Kim JM, Eckmann L, Savidge TC, et al. Apoptosis of human intestinal epithelial cells after bacterial invasion. J Clin Invest 1998;102:1815-23.
27. Panja A, Goldberg S, Eckmann L, et al. The regulation and functional consequence of pro-inflammatory cytokine binding on human intestinal epithelial cells. J Immunol 1998;161:3675-84.
28. Pugin J, Schürer-Maly C, Leturcq D, et al. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc Natl Acad Sci USA 1993;90:2744-8.
29. Cario E, Rosenberg IM, Brandwein SI, et al. Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors. J Immunol 2000;164:966-72.
30. Tapping RI, Akashi S, Miyake K, et al. Toll-like receptor 4, but not Toll-like receptor 2, is a signaling receptor for Escherichia and Salmonella lipopolysaccharides. J Immunol 2000;165:5780-7.
31. Beutler B. TLR4: Central component of the sole mammalian LPS sensor. Curr Opin Immunol 2000;12:20.
32. Shimazu R, Akashi H, Ogata F, et al. MD-2, a molecule that confers lipopolysaccharide responsiveness in toll-like receptor 4. J Exp Med 1999;189:177.
33. Nomura F, Akashi S, Sakao Y, et al. Cutting edge: Endotoxin tolerance in mouse peritoneal macrophages correltes with down-regulation of surface toll-like receptor 4 expression. J Immunol 2000;164:3476-9.
34. Stevens C, Walz G, Singavam C, et al. Tumor necrosis factor-alpha, interleukin-1 beta and interleukin-6 expression in inflammatory bowel disease. Dig Dis Sci 1992;37:818-26.
35. MacDonald TT, Huchings P, Choy MY, et al. Tumor necrosis factor-alpha and interferon-gamma production measured at the single-cell level in normal and inflammed human intestine. Clin Exp Immunol 1990;81:301-5.
36. Braegger CP, Nicholls S, Murch SH, et al. Tumor necrosis factor alpha in stool as a marker of intestinal inflammation. Lancet 1992 339:89-91.
37. van Dullemen H, van Deventer SJ, Hommes DW, et al. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 1995;109:129-35.
38. Targan SR, Hanauer SB, van Deventer SJ, et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. N Engl J Med 1997;337:1029-35.